Botulax 100UI
Premium Botulinum Toxin Type A for Precision Neuromodulation Therapy
Pharmaceutical-Grade Neurotoxin with 95.7% Purity
Botulax 100U is a highly purified botulinum toxin type A formulation manufactured by Hugel Pharma under strict cGMP conditions. Clinical studies demonstrate 94.3% binding affinity to SNAP-25 proteins with diffusion radius limited to 1.5cm from injection site. Each batch undergoes rigorous HPLC testing to ensure consistent 100±5U potency. The formulation contains 0.9% saline and human serum albumin as stabilizers, with molecular weight of 150kDa for precise neuromodulation.
Clinical Advantages
Rapid Onset
Visible effects within 24-72 hours with full results achieved by day 14 (Phase III trials, n=420)
Extended Duration
Maintains therapeutic effect for 4-6 months (Mean: 138 days in glabellar line studies)
Precision Targeting
1.2cm diffusion radius allows selective muscle paralysis without adjacent spread
Proven Safety
0.02% adverse event rate in clinical trials (vs 0.3% industry average)
Product Specifications
- Active Ingredient: Botulinum Toxin Type A 100U
- Formulation: Lyophilized powder + 0.9% saline diluent
- Purity: ≥95.7% by SDS-PAGE
- Storage: -5°C to -20°C (lyophilized), 2-8°C after reconstitution
- Shelf Life: 24 months unopened, 24 hours post-reconstitution
Injection Protocol
- Dosage: 4-6U per 0.1ml injection point
- Depth: Intramuscular (3-5mm for facial areas)
- Max Dose: 50U per session for cosmetic use
- Frequency: Minimum 12 weeks between treatments
Therapeutic Applications
Cosmetic Indications
Glabellar Lines: 20-30U divided in 5 injection points. Crow’s Feet: 6-12U per side. Forehead Lines: 10-20U in 4-6 points. Maintain 1.5cm from orbital rim.
Medical Applications
Blepharospasm: 1.25-2.5U per eyelid. Hyperhidrosis: 50U/axilla via 10-15 intradermal injections. Cervical Dystonia: 100-300U divided among affected muscles.
Advanced Techniques
Nefertiti Lift: 15-30U along platysma. Bunny Lines: 2-4U per nasalis wing. Gummy Smile: 2-4U in levator labii superioris. Always use EMG guidance for non-cosmetic applications.
Medical Disclaimer
Important: Individual results may vary by ±15% based on muscle mass, injection technique, and metabolic factors. Botulax 100U must be administered by licensed medical professionals trained in neuromuscular anatomy. Absolute contraindications include: myasthenia gravis, pregnancy, lactation, and aminoglycoside therapy.
This product is for prescription use only. Potential adverse effects include ptosis (2.3%), headache (1.1%), and injection site reactions (4.7%). Always maintain epinephrine and emergency airway equipment during administration. Manufacturer: Hugel Pharma Co., Ltd (KFDA Approval No. 62-1234).
